EBCC 6: Variations in treatment with aromatase inhibitors.

Bookmark and Share
Published: 4 Dec 2008
Views: 13593
Professor Per Lønning, Medical Oncologist, University of Bergen
Professor Per Lønning discusses the differences between the aromatase inhibitors letrozole, anastrozole, and exemustane. Prof. Lonning also highlights the lack of definative results to confirm which (if any) is superior but speaks of the progress that has been made towards this end.